Europe Infertility Treatment Devices and Equipment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product ; Procedure ; End User and Country

The Europe infertility treatment devices and equipment market is expected to reach US$ 444.27 million in 2027 from US$ 241.64 million in 2019. The market is estimated to grow with a CAGR of 8.1% from 2020-2027.
The growth of this market can be attributed to key driving factors such as a high rise in in vitro fertilization techniques and an increase in awareness among the population regarding sperm & egg donation. However, risks associated with reproductive techniques is likely to hamper the market growth.
Infertility is defined as the inability to get pregnant or conceive.It can be primary infertility (refers to couples who cannot become pregnant after at least one year of coitus without using birth control methods) and secondary infertility (refers to couples who cannot get pregnant more than once).

There are many different infertility treatment devices and equipment options available for patients.Many factors contribute to the low fertility rate; thus, in the coming years, the number of patients seeking infertility treatment will rise.

Many companies have developed novel devices and procedures for simple, effective, and cost-effective fertility treatment.
There has been a rising prevalence of infertility in males and females due to various factors, such as anatomical, physiological, and genetic factors.Many environmental and acquired factors also influence fertility and may lead to infertility.

Menstrual and ovulation dysfunction and uterine factors are the most common causes of infertility.The adoption of reproductive technology in Germany has led to a significant rise in vitro fertilization.

According to the German IVF Registry (DIR), Germany is among the leading countries in Europe, offering successful IVF treatment.Across Germany every year, more than 100,000 IVF procedures are performed.

More than 35% of IVF treatment is successful. Therefore, the country is experiencing a rise in the number of fertility clinics. Also, health insurance offers women great help to conceive a baby through IVF procedures and ART cycles. The approximate cost of IVF and ICSI is between US$ 1,291 to US$ 2,582 (EUR 1,100 to EUR 2,200). In the UK, the National Health Service (NHS) offers IVF treatment free of cost since 2004, with specialized guidelines based on the women’s age. The NHS provides three complete cycles of IVF to women of 40 years of age and under. At the same time, it gives a single cycle for women between the ages of 40 to 42 years. Thus, the rise in demand for the IVF technique drives the growth of the infertility treatment devices and equipment market.
In the Europe region, as per the Worldometer as of October 7, 2020, in Spain, Italy, Germany, France, UK and Netherlands, Belgium, and Luxembourg, the number of cases is 659,334, 298,156; 273,477; 452,763; 394,257; 93,778; 102,295; 46,687; 7,907 respectively and number of deaths are also high.As per the joint statement of the American Society for Reproductive Medicine (ASRM), European Society of Human Reproduction and Embryology (ESHRE), and International Federation of Fertility Societies (IFFS), infertility is the impairment of reproductive capacity; affecting 8–12% of couples of reproductive age, harming their physical and mental well-being.

It is time-sensitive, and prognosis worsens with age.Infertility is a disease, and once the risk of COVID-19 infection starts decreasing, ART treatments can be continued for any clinical indication, in line with local regulations.

However, the guidance states that vigilance and measured steps must be taken for safe practice and minimize the risks related to COVID-19 positive patients or staff during treatment.
Based on product, the infertility treatment devices and equipment market is segmented into ovum aspiration pumps, sperm analyzer systems, sperm separation devices, micromanipulator systems, incubators, and others.The ovum aspiration pumps segment held the largest share of the market in 2019.

The same segment is estimated to register the highest CAGR in the market during the forecast period.
Based on the procedure, the infertility treatment devices and equipment market is segmented into assisted reproductive technology, artificial insemination, and fertility surgery. The artificial insemination segment held the largest share of the market in 2019, whereas the assisted reproductive technology segment is anticipated to register the highest CAGR in the market during the forecast period.
Based on end user, the infertility treatment devices and equipment market is categorized into fertility clinics, hospitals and other healthcare facilities, and clinical research institutes.The fertility clinics segment held the largest share of the market in 2019.

The same segment is anticipated to register the highest CAGR during the forecast period.
Some of the major primary and secondary sources for infertility treatment devices and equipment market included in the report are the National Health Service (UK) and German IVF Registry (DIR), among others.